Influence of an additional application of iodine-127 on the pharmacokinetics of radioactive iodine-131 during a radioiodine therapy in patients with Graves' disease.

被引：0
|
作者：
Moka, D [1 ]
Reinholz, U [1 ]
Eschner, W [1 ]
Wellner, U [1 ]
Schicha, H [1 ]
机构：
[1] Univ Cologne, D-5000 Cologne 41, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2003年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1189
引用
收藏
页码：332P / 333P
页数：2
相关论文
共 50 条
  • [41] Identification of patients with Graves’ disease who benefit from high-dose radioactive iodine therapy
    Shiro Watanabe
    Shozo Okamoto
    Kazumasa Akikawa
    Noriyuki Miyamoto
    Miyuki Okamura-Kawasaki
    Yuko Uchiyama
    Junki Takenaka
    Takuya Toyonaga
    Kenji Hirata
    Kohsuke Kudo
    Annals of Nuclear Medicine, 2022, 36 : 923 - 930
  • [42] Could effective iodine-131 half-life be extended by lithium carbonate in Graves' disease patients: Results from a retrospective analysis
    Gao, Xuemei
    Wu, Binbin
    Zhou, Qian
    Liu, Yan
    Wang, Ruihua
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (06): : 1711 - 1716
  • [43] Hospital discharge policy in patients receiving iodine-131 therapy for thyroid carcinoma based on monitoring of radiation dose rate and radioiodine urinary excretion
    Beiki, D.
    Fallahi, B.
    Dadashzadeh, S.
    Shahhosseini, S.
    Eftekhari, M.
    Fard-Esfahani, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S355 - S356
  • [44] TREATMENT OF HYPERTHYROIDISM WITH RADIOACTIVE IODINE (I-131), USE OF AN INDIVIDUALLY CALCULATED DOSE IN 241 MALE PATIENTS WITH GRAVES DISEASE
    BLAHD, WH
    HAYS, ME
    JOURNAL OF NUCLEAR MEDICINE, 1970, 11 (06) : 382 - &
  • [45] Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
    C. Happel
    W. T. Kranert
    D. Gröner
    J. Baumgarten
    J. Halstenberg
    B. Bockisch
    A. Sabet
    F. Grünwald
    Endocrine, 2021, 73 : 125 - 130
  • [46] Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves' disease
    Happel, C.
    Kranert, W. T.
    Groener, D.
    Baumgarten, J.
    Halstenberg, J.
    Bockisch, B.
    Sabet, A.
    Gruenwald, F.
    ENDOCRINE, 2021, 73 (01) : 125 - 130
  • [47] Guiding the postoperative radioactive iodine-131 therapy for patients with papillary thyroid carcinoma according to the prognostic risk groups: a SEER-based study
    Yang, Yuping
    Gan, Mingyu
    Yi, Kun
    Han, Shanshan
    Lin, Zijing
    Shi, Yanling
    Ming, Jia
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (19) : 17147 - 17157
  • [48] Guiding the postoperative radioactive iodine-131 therapy for patients with papillary thyroid carcinoma according to the prognostic risk groups: a SEER-based study
    Yuping Yang
    Mingyu Gan
    Kun Yi
    Shanshan Han
    Zijing Lin
    Yanling Shi
    Jia Ming
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17147 - 17157
  • [49] Revised nuclear regulatory commission regulations for release of patients administered radioactive materials: Outpatient iodine-131 anti-B1 therapy
    Siegel, JA
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (08) : 28S - 33S
  • [50] Ultrasound combined with Ki-67 to construct the prognostic model for radioactive iodine therapy outcomes in Graves' disease patients
    Wang, Yuegui
    Hong, Liwei
    Yang, Caiyun
    Lv, Guorong
    Wang, Kangjian
    Huang, Xuepeng
    Shen, Haolin
    ENDOCRINE CONNECTIONS, 2024, 13 (02)
12345